Clinical Trial Update: A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of repeat dosing of a fluticasone furoate and GW642444M combination in healthy subjects and in individuals …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• GW642444M (GW642444M)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED